Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

New pharmacokinetic/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection

(2015) Soon-Ee Cheah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

(2015) Roger L Nation et al.   LANCET INFECTIOUS DISEASES

Colistin: How should It Be Dosed for the Critically Ill?

(2015) Cornelia Landersdorfer et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?

(2014) R. L. Nation et al.   CLINICAL INFECTIOUS DISEASES

Product information for parenteral colistin varies substantially across Europe

(2014) U. Theuretzbacher   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

(2013) Luisa Sorlí et al.   BMC INFECTIOUS DISEASES

Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring

(2013) Stefanie M. Bode-Böger et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2012) Zakuan Z. Deris et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

‘Old’ antibiotics for emerging multidrug-resistant bacteria

(2012) Phillip J. Bergen et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin pharmacokinetics: the fog is lifting

(2011) W. Couet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Convulsions and apnoea in a patient infected with New Delhi metallo-β-lactamase-1 Escherichia coli treated with colistin

(2011) Herbert D. Spapen et al.   JOURNAL OF INFECTION

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nephrotoxicity of Colistin: New Insight into an Old Antibiotic

(2009) Matthew E. Falagas et al.   CLINICAL INFECTIOUS DISEASES